Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ELTP
$0.28
-1.36%
ELTP
· Elite Pharmaceuticals Inc /Nv/
$0.28
0.00 (-1.36%)
At close · Sep 2
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$302.68M
Shares
1.08B
All earnings calls
Earnings call · FY2026 Q3
Elite Pharmaceuticals Inc (ELTP) Q3 2026 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$31.59M
+119.9% YoY
Diluted EPS
$0.01
Gross margin
41.0%
-1.6 pp YoY
Net income
$18.59M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 17, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Feb 17, 2026 · complete as-filed document